plemmons and co-authors disclosed no relevant relationships with industry..
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..
plemmons and co-authors disclosed no relevant relationships with industry..
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..